ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,354.03
1.18%
Dow Jones
38,807.33
0.25%
US Dollar vs MXN
17.4992
-0.11%
Brent Oil
78.585
0.03%
Bitcoin
71,047.17
-0.04%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) Noticias

ME 23andMe Holding Company

0.4443
-0.0058 (-1.29%)
05 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
23andMe Holding Company ME NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0058 -1.29% 0.4443 18:16:57
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.46 0.4243 0.4634 0.4419 0.4501
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/6/202406:00GLOBE23andMe Launches New Genetic Report on Bipolar Disorder
04/6/202406:00GLOBE23andMe and the Colorectal Cancer Alliance Collaborate to..
03/6/202407:06EDGAR2Form 8-K - Current report
03/6/202407:00GLOBE23andMe Therapeutics Announces Positive Preliminary Phase 2..
29/5/202407:00GLOBELargest study on the LRRK2 variant leads to discoveries..
24/5/202415:06EDGAR2Form 8-K - Current report
23/5/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202415:07EDGAR2Form 8-K - Current report
23/5/202415:05GLOBE23andMe Reports Fourth Quarter and Full Year Fiscal 2024..
21/5/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202406:00GLOBELemonaid Health Now Offers Prescription ED Medication..
10/5/202415:06EDGAR2Form 8-K - Current report
09/5/202415:50GLOBE23andMe to Report Q4 and Full Year FY2024 Financial Results
30/4/202410:00BWPotter Handy Law Firm Represents Nearly 5,000 Clients in..
24/4/202415:05GLOBE23andMe to Present Preliminary Efficacy and Biomarker Data..
18/4/202407:00GLOBE23andMe announces CEO’s intention to pursue a potential..
05/4/202415:05GLOBE23andMe to Present Data on Two Clinical Stage..
20/3/202406:30GLOBE23andMe Initiates Phase 1 Clinical Trial for its Dual..
19/3/202407:00GLOBE23andMe Launches New Feature Connecting Customers to..
06/3/202406:30GLOBE23andMe Launches New Genetic Reports on Common Forms of..
05/3/202415:30GLOBE23andMe Announces Three Presentations from Clinical-Stage..
21/2/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202415:03EDGAR2Form 8-K - Current report
07/2/202415:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
06/2/202406:00BWMoneta Gold and Nighthawk Gold Complete At-Market Merger to..
31/1/202406:50EDGAR2Form 8-K - Current report
30/1/202421:12GLOBE23andMe Launches Month-Long Initiative to Amplify ARRAY’s..
30/1/202416:00BWNighthawk Gold Obtains Final Court Order for the Proposed..
24/1/202415:05GLOBE23andMe to Report FY2024 Third Quarter Financial Results
22/1/202407:00BWMoneta Gold and Nighthawk Gold Announce the Proposed..
08/1/202406:45EDGAR2Form 8-K - Current report
19/12/202307:00GLOBE23andMe announces further expansion of 23ME-00610 Phase 1/2a..
01/12/202315:06EDGAR2Form 8-K/A - Current report: [Amend]
28/11/202306:15BWNighthawk and Moneta Announce At-Market Merger to Create a..
21/11/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:06EDGAR2Form 8-K - Current report
08/11/202315:29EDGAR2Form 8-K - Current report
08/11/202315:05GLOBE23andMe Reports Second Quarter Fiscal 2024 Financial Results
07/11/202307:00GLOBE23andMe Launches Total Health™, its..
06/11/202307:15EDGAR2Form 8-K - Current report
06/11/202307:00GLOBE23andMe Announces Updated Safety and Preliminary Efficacy..
31/10/202307:00GLOBE23andMe Launches Health Action Plan to Provide Personalized..
30/10/202315:05EDGAR2Form 8-K - Current report
30/10/202307:00GLOBE23andMe Announces Collaboration Extension with a New Data..
27/10/202315:06EDGAR2Form 8-K - Current report
25/10/202315:05GLOBE23andMe to Report FY2024 Second Quarter Financial Results
10/10/202315:17EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
ME
23andMe
LSE
AR24
Places Tr 55
LSE
39VX
Res.mtg 17 M1ca
BIT
P1T2Z3
NLBNPIT1T2Z3 20241220 19
ASX
FRXN
Flexiroam
EU
BFCFX
Banque Federative du Cre...
USOTC
DLELY
Delta Electronics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados